Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/PAR stock hub

NSE/PAR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/PARis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/PAR

In the news

Latest news · NSE/PAR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E8.3

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC14.7

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/PAR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

INR

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	121
Employees Change	-1%
Employees Change Percent	-0.82
Enterprise value	INR 819.1M
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE04LG01015
Last refreshed	2026-05-10
Market cap	INR 1.2B
Price	INR 94
Price currency	INR
Rev Per Employee	8,791,297.52x
Sector	Healthcare
Sic	2833
Symbol	nse/PAR
Website	https://www.pardrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.01%
EV Earnings	5.89x
EV/EBIT	5.68x
EV/EBITDA	4.49x
EV/Sales	0.77x
P/B ratio	1.09x
P/E ratio	8.32x
P/S ratio	1.09x
PE Ratio10 Y	13.88x
PE Ratio3 Y	15.49x
PE Ratio5 Y	16.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.57%
EBITDA Margin	17.14%
Gross margin	57.43%
Gross Profit	INR 610.9M
Gross Profit Growth	-6.01%
Gross Profit Growth Q	34.78%
Gross Profit Growth3 Y	5.56%
Gross Profit Growth5 Y	11.67%
Net Income	INR 139.1M
Net Income Growth	-9.86%
Net Income Growth Q	729.97%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	10.49%
Net Income Growth5 Y	9.63%
Pretax Margin	17.63%
Profit Margin	13.07%
Profit Per Employee	INR 1.1M
Profitable Years	10
Roa5y	11.08
Roe5y	18.34
ROIC	14.75
Roic5y	24.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.67%
Cagr3y	-17.22%
Cagr5y	9.04%
Div CAGR5	0%
EPS Growth	-9.77
EPS Growth Q	729.8
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	10.51
EPS Growth5 Y	9.64
Revenue Growth	4.84x
Revenue Growth Q	37.22x
Revenue Growth Quarters	1x
Revenue Growth Years	7x
Revenue Growth3 Y	4.45x
Revenue Growth5 Y	12.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 338.6M
Equity	INR 1.1B
Interest Coverage	641.4
Net Cash	INR 338.6M
Net Cash By Market Cap	INR 29.25
Net Cash Growth	80.25%
Net Debt EBITDA	INR -1.86
Net Debt Equity	INR -0.32
Tangible Book Value	INR 1.1B
Tangible Book Value Per Share	INR 86.6
WACC	4.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.05%
Dividend per share	INR 0
Last Dividend	INR 1.25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.66%
200-day SMA	97.44
3Y total return	-43.29%
50-day SMA	90.41
50-day SMA vs 200-day SMA	50under200
5Y total return	54.12%
All Time High	348.5
All Time High Change	-73.02%
All Time High Date	2024-12-02
All Time Low	13.1
All Time Low Change	617.56%
All Time Low Date	2020-03-30
ATR	3.34
Beta	-0.04
Beta1y	0.82
Beta2y	0.44
Ch YTD	-7.17
High	95.55
High52	122.4
High52 Date	2025-09-18
High52ch	-23.22%
Low	93.11
Low52	78.05
Low52 Date	2026-03-30
Low52ch	20.44%
Ma50ch	3.97%
Price vs 200-day SMA	-3.53%
RSI	60.05
RSI Monthly	41.08
RSI Weekly	48.57
Sharpe ratio	-0.19x
Sortino ratio	-0.13
Total Return	0.05%
Tr YTD	-7.17
Tr1m	5.35%
Tr1w	4.18%
Tr3m	2.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 144.3M
Operating Income Growth	-26.18
Operating Income Growth Q	896.9
Operating Income Growth3 Y	0.79
Operating Income Growth5 Y	4.28
Operating margin	13.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,371,728%
Shares Insiders	77.25%
Shares Out	12,304,636
Shares Qo Q	0.08%
Shares Yo Y	-0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	5,110.8x
Bv Per Share	86.6
Ch1m	5.35
Ch1w	4.18
Ch1y	-7.66
Ch3m	2.49
Ch3y	-43.29
Ch5y	53.09
Ch6m	-4.79
Change	0.13%
Change From Open	0.62
Close	93.88
Days Gap	-0.49
Depreciation Amortization	38,044,750
Dollar Volume	405,516
Earnings Date	2026-05-14
EBIT	INR 144.3M
EBITDA	INR 182.4M
EPS	INR 11.31
F Score	1
Fiscal Year End	March
Founded	1,982
Graham Number	148.41867
Graham Upside	57.89
Income Tax	INR 48.4M
Is Primary Listing	1
Last Earnings Date	2026-02-10
Last Report Date	2025-12-31
Last Split Date	2021-04-27
Last Split Type	Forward
Lynch Fair Value	INR 109
Lynch Upside	15.79
Ma150	95.13
Ma150ch	-1.18%
Ma20	92.08
Ma20ch	2.09%
Next Earnings Date	2026-05-14
Open	93.42
Position In Range	36.48
Price Date	2026-05-08
Price EBITDA	INR 6.35
Ptbv Ratio	1.09
Relative Volume	0.78x
Revenue	1,063,747,000x
Tax By Revenue	4.55x
Tax Rate	25.83%
Tr6m	-4.79%
Volume	4,314

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/PAR pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/PAR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/PAR?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+77.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

NSE/PAR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.0

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

-0.04

Less volatile than the market

Sharpe ratio

-0.19

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/PAR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/PAR stock rating?

nse/PAR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/PAR analysis?

The full report lives at /stocks/nse/PAR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/PAR?

The latest report frames nse/PAR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/PAR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.